Showing results (311-320 of 477) with videos related to
Sort By:
Pageof 48
JACC. Cardiovascular Interventions|May 26, 2009
A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trialBernard Chevalier, Carlo Di Mario, Franz-Josef Neumann, et al.Circulation. Cardiovascular Interventions|September 30, 2015
Fixed and Modifiable Correlates of Drug-Eluting Stent Thrombosis From a Large All-Comers Registry: Insights From ADAPT-DESBruce R Brodie, Ankit Garg, Thomas D Stuckey, et al.JACC. Cardiovascular Interventions|September 24, 2011
Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT RegistryYoung Joon Hong, Myung Ho Jeong, Alexander Abizaid, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 8, 2023
Association between three-year mortality after transcatheter aortic valve implantation and paravalvular regurgitation graded by videodensitometry in comparison with visual gradingHesham Elzomor, Timotheus J Neumann, Linus Boas, et al.JACC. Cardiovascular Interventions|December 4, 2018
Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli: Insights From the CHOICE Trial and the CHOICE-Extend RegistryMohammad Abdelghani, Nader Mankerious, Abdelhakim Allali, et al.Journal of the American College of Cardiology|January 29, 2011
Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosisEnno Boudriot, Holger Thiele, Thomas Walther, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trialPatrick W Serruys, Andrew T L Ong, Jan J Piek, et al.European Heart Journal|August 19, 2005
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-upDebabrata Mukherjee, Eric J Topol, Michel E Bertrand, et al.Circulation|August 5, 2009
Sirolimus-eluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: results from the prospective multicenter German Cypher RegistryAhmed A Khattab, Christian W Hamm, Jochen Senges, et al.Journal of the American College of Cardiology|March 26, 2011
Stent thrombosis and bleeding complications after implantation of sirolimus-eluting coronary stents in an unselected worldwide population: a report from the e-SELECT (Multi-Center Post-Market Surveillance) registryPhilip Urban, Alexandre Abizaid, Adrian Banning, et al.Pageof 48